Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.29
-0.52 (-8.95%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Recursion Pharmaceuticals (RXRX) Revenue by Segment
History
| Date | Operating | Grant |
|---|---|---|
| Sep 30, 2024 | 64.60M | - |
| Jun 30, 2024 | 48.62M | 1.01M |
| Mar 31, 2024 | 45.23M | 1.00M |
| Dec 31, 2023 | 43.88M | 699.00K |
| Sep 30, 2023 | 46.93M | 432.00K |
| Jun 30, 2023 | 49.88M | 1.11K |
| Mar 31, 2023 | 46.52M | - |
| Dec 31, 2022 | 39.68M | - |
| Sep 30, 2022 | 28.51M | 88.11K |
| Jun 30, 2022 | 17.95M | 122.00K |
| Mar 31, 2022 | 12.80M | 150.00K |
| Dec 31, 2021 | 10.00M | 178.00K |
| Sep 30, 2021 | 10.05M | 285.00K |
| Jun 30, 2021 | 8.41M | 414.00K |
| Mar 31, 2021 | 5.91M | 551.00K |
| Dec 31, 2020 | 3.41M | 549.00K |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.